Cargando…
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724876/ https://www.ncbi.nlm.nih.gov/pubmed/33298087 http://dx.doi.org/10.1186/s13046-020-01780-y |
| _version_ | 1783620606748524544 |
|---|---|
| author | Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu |
| author_facet | Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu |
| author_sort | Teng, Fei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7724876 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77248762020-12-09 Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu J Exp Clin Cancer Res Correction BioMed Central 2020-12-09 /pmc/articles/PMC7724876/ /pubmed/33298087 http://dx.doi.org/10.1186/s13046-020-01780-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title | Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_full | Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_fullStr | Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_full_unstemmed | Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_short | Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_sort | correction to: lncrna mylk-as1 facilitates tumor progression and angiogenesis by targeting mir-424-5p/e2f7 axis and activating vegfr-2 signaling pathway in hepatocellular carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724876/ https://www.ncbi.nlm.nih.gov/pubmed/33298087 http://dx.doi.org/10.1186/s13046-020-01780-y |
| work_keys_str_mv | AT tengfei correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT zhangjuxiang correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT changqimeng correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT wuxubo correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT tangweiguo correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT wangjianfa correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT fengjinfeng correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT zhangziping correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT huzhiqiu correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma |